Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6735
Reference
Drug alert 05/2020
Name
Drug alert class 2 no 5 2018: action within 48 hours [Medreich PLC - Ranitidine]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Medreich Plc is recalling all unexpired stock of Ranitidine 150mg and 300mg tablets from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.
Contact Name
Contact Email
Contact Address
Contact Phone
Created
2020-02-03 00:00:00
Click to go back to homepage